Does early identification of high work related stress affect pharmacological treatment of primary care patients? - analysis of Swedish pharmacy dispensing data in a randomised control study

Pernilla J Bjerkeli, Ingmarie Skoglund, Kristina Holmgren, Pernilla J Bjerkeli, Ingmarie Skoglund, Kristina Holmgren

Abstract

Background: The study is part of a randomised controlled trial with the overall aim to evaluate if use of the Work Stress Questionnaire (WSQ), combined with feedback at consultation, can be used by healthcare professionals in primary health care to prevent sickness absence. The specific aim of the present study was to investigate whether there were differences in pharmacy dispensing of prescription medications between the intervention group and the control group.

Methods: The study was a randomized controlled trial. Non-sick-listed employed women and men, aged 18 to 64 years, seeking care at primary health care centres (PHCCs) were eligible participants. The intervention included early identification of work-related stress by the WSQ, general practitioner (GP) training and GP feedback at consultation. Pharmacy dispensing data from the Swedish Prescription Drug Register for a period of 12 months following the intervention was used. Primary outcomes were the number of different medications used, type of medication and number of prescribing clinics. Data was analysed using Mann Whitney U tests and chi-square tests.

Results: The study population included 271 individuals (132 in the intervention group and 139 in the control group). The number of different medications used per individual did not differ significantly between the control group (median 4.0) and the intervention group (median 4.0, p-value 0.076). The proportion of individuals who collected more than 10 different medications was higher in the control group than in the intervention group (15.8% versus 4.5%, p = 0.002). In addition, the proportion of individuals filling prescriptions issued from more than three different clinics was higher in the control group than in the intervention group (17.3% versus 6.8%, p = 0.007).

Conclusion: Systematic use of the WSQ combined with training of GPs and feedback at consultation may affect certain aspects of pharmacological treatment in primary health care patients. In this randomised control trial, analysis of pharmacy dispensing data show that patients in the intervention group had less polypharmacy and filled prescriptions issued from a smaller number of different clinics.

Trial registration: ClinicalTrials.gov. Identifier: NCT02480855. Registered 20 May 2015.

Keywords: Intervention; Medication use; Pharmacy dispensing data; Stress; Work related stress.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. WHO. Stress at the workplace [Available from: .
    1. Holmgren K, Hensing G, Dellve L. The association between poor organizational climate and high work commitments, and sickness absence in a general population of women and men. J Occup Environ Med. 2010;52(12):1179–1185. doi: 10.1097/JOM.0b013e3181fc5c1a.
    1. Milczarek M, Rial-González E, Schneider E. Occupational safety and health in figures: stress at work-facts and figures: Office for Official Publications of the European Communities; 2009.
    1. Houdmont J, Cox T, Griffiths A. Work-related stress case definitions and prevalence rates in national surveys. Occup Med (Lond) 2010;60(8):658–661. doi: 10.1093/occmed/kqq138.
    1. Eurostat Statistics explained. Labour market participation statistics 2014 [Available from: . Accessed 22 Mar 2020.
    1. Holmgren K, Dahlin-Ivanoff S, Bjorkelund C, Hensing G. The prevalence of work-related stress, and its association with self-perceived health and sick-leave, in a population of employed Swedish women. BMC Public Health. 2009;9:73. doi: 10.1186/1471-2458-9-73.
    1. Schneiderman N, Ironson G, Siegel SD. Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol. 2005;1:607–628. doi: 10.1146/annurev.clinpsy.1.102803.144141.
    1. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298(14):1685–1687. doi: 10.1001/jama.298.14.1685.
    1. Harvey SB, Modini M, Joyce S, Milligan-Saville JS, Tan L, Mykletun A, et al. Can work make you mentally ill? A systematic meta-review of work-related risk factors for common mental health problems. Occup Environ Med. 2017;74(4):301–310. doi: 10.1136/oemed-2016-104015.
    1. Bahrami-Ahmadi A, Mortazavi SA, Soleimani R, Nassiri-Kashani MH. The effect of work- related stress on development of neck and shoulder complaints among nurses in one tertiary hospital in Iran. Med J Islam Repub Iran. 2016;30:471.
    1. Hauke A, Flintrop J, Brun E, Rugulies R. The impact of work-related psychosocial stressors on the onset of musculoskeletal disorders in specific body regions: a review and meta-analysis of 54 longitudinal studies. Work Stress. 2011;25(3):243–256. doi: 10.1080/02678373.2011.614069.
    1. Byrne DG, Espnes GA. Occupational stress and cariovascular disease. 2008.
    1. Eskildsen A, Andersen LP, Pedersen AD, Vandborg SK, Andersen JH. Work-related stress is associated with impaired neuropsychological test performance: a clinical cross-sectional study. Stress. 2015;18(2):198–207. doi: 10.3109/10253890.2015.1004629.
    1. Eng A, Mannetje A, Pearce N, Douwes J. Work-related stress and asthma: results from a workforce survey in New Zealand. J Asthma. 2011;48(8):783–789. doi: 10.3109/02770903.2011.608459.
    1. Holmgren K, Fjallstrom-Lundgren M, Hensing G. Early identification of work-related stress predicted sickness absence in employed women with musculoskeletal or mental disorders: a prospective, longitudinal study in a primary health care setting. Disabil Rehabil. 2013;35(5):418–426. doi: 10.3109/09638288.2012.695854.
    1. Wynne-Jones G, Buck R, Varnava A, Phillips CJ, Main CJ. Impacts on work performance; what matters 6 months on? Occup Med (Lond) 2011;61(3):205–208. doi: 10.1093/occmed/kqr005.
    1. Hassard J, Teoh KR, Visockaite G, Dewe P, Cox T. The cost of work-related stress to society: a systematic review. J Occup Health Psychol. 2017.
    1. Balayssac D, Pereira B, Virot J, Lambert C, Collin A, Alapini D, et al. Work-related stress, associated comorbidities and stress causes in French community pharmacies: a nationwide cross-sectional study. PeerJ. 2017;5:e3973. doi: 10.7717/peerj.3973.
    1. d'Errico A, Cardano M, Landriscina T, Marinacci C, Pasian S, Petrelli A, et al. Workplace stress and prescription of antidepressant medications: a prospective study on a sample of Italian workers. Int Arch Occup Environ Health. 2011;84(4):413–424. doi: 10.1007/s00420-010-0586-3.
    1. Holmgren K, Sandheimer C, Mardby AC, Larsson ME, Bultmann U, Hange D, et al. Early identification in primary health care of people at risk for sick leave due to work-related stress - study protocol of a randomized controlled trial (RCT) BMC Public Health. 2016;16(1):1193. doi: 10.1186/s12889-016-3852-9.
    1. Holmgren K, Hensing G, Bültmann U, Hadzibajramovic E, Larsson MEH. Does early identification of work-related stress, combined with feedback at GP-consultation, prevent sick leave in the following 12 months? A randomized controlled trial in primary health care. BMC Public Health. 2019;19(1):1110. doi: 10.1186/s12889-019-7452-3.
    1. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390. doi: 10.1136/bmj.a2390.
    1. Holmgren K, Hensing G, Dahlin-Ivanoff S. Development of a questionnaire assessing work-related stress in women - identifying individuals who risk being put on sick leave. Disabil Rehabil. 2009;31(4):284–292. doi: 10.1080/09638280801931287.
    1. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish prescribed drug register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735. doi: 10.1002/pds.1294.
    1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi: 10.1186/s12877-017-0621-2.
    1. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289(23):3145–3151. doi: 10.1001/jama.289.23.3145.
    1. Wikberg C, Pettersson A, Westman J, Bjorkelund C, Petersson EL. Patients' perspectives on the use of the Montgomery-Asberg depression rating scale self-assessment version in primary care. Scand J Prim Health Care. 2016;34(4):434–442. doi: 10.1080/02813432.2016.1248635.
    1. Dowrick C, Leydon GM, McBride A, Howe A, Burgess H, Clarke P, et al. Patients' and doctors' views on depression severity questionnaires incentivised in UK quality and outcomes framework: qualitative study. BMJ. 2009;338:b663. doi: 10.1136/bmj.b663.
    1. Paddison CA, Abel GA, Roland MO, Elliott MN, Lyratzopoulos G, Campbell JL. Drivers of overall satisfaction with primary care: evidence from the English general practice patient survey. Health Expect. 2015;18(5):1081–1092. doi: 10.1111/hex.12081.
    1. Hovstadius B, Hovstadius K, Åstrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10(1):16.
    1. Swedish Board of Health and Welfare. Statistikdatabasen Sweden2018 [Available from: . Accessed June 2019.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner